Riyadh Biotechnology Summit 2026: Under the patronage of the Crown Prince and the future of innovation
Under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince, Prime Minister and Chairman of the Board of Directors of the Riyadh Biotechnology Center Foundation - may God protect him - the Saudi capital is preparing to host an exceptional medical and technological event, as the fourth edition of the "Riyadh Global Biotechnology Summit" will be held from September 14 to 16, 2026.
Strategic partnership to promote health innovation
This summit is organized by the Health Affairs Department of the Ministry of National Guard, represented by the King Abdullah International Medical Research Center (KAIMRC), in strategic partnership with the Ministry of Investment. This partnership aims to unify efforts between the health and investment sectors to solidify the Kingdom's position as a leading global destination in this vital field.
On this occasion, His Royal Highness Prince Abdullah bin Bandar bin Abdulaziz, Minister of the National Guard and member of the Board of Directors of the Riyadh Biotechnology Center Foundation, expressed his deepest gratitude to His Royal Highness the Crown Prince for his generous patronage of the summit. His Highness affirmed that this patronage embodies the Crown Prince's unwavering support for the biotechnology sector and empowers national efforts aimed at achieving the objectives of the "National Biotechnology Strategy" previously launched by His Highness.
The importance of the summit in the context of Vision 2030
This summit is not merely a passing event, but a cornerstone of the national transformation journey, as its objectives align directly with the aspirations of the Kingdom's Vision 2030 to diversify the national economy and build a knowledge-based economy. The summit's significance stems from its focus on:
- Developing a bioeconomy: Working to transform scientific research into tangible economic products that contribute to the non-oil GDP.
- Attracting quality investments: Attracting major international companies to invest in advanced pharmaceutical industries within the Kingdom.
- Health and pharmaceutical security: Enhancing the Kingdom’s capabilities in the local manufacturing of vaccines and biological medicines, thereby raising the level of national and regional health security.
A global platform for future leaders
The Riyadh Global Biomedical Summit is considered one of the most important international platforms that brings together the world's leading minds. The fourth edition is expected to see wide participation, including:
- Government leaders and decision-makers from various countries around the world.
- CEOs of major global pharmaceutical and biotechnology companies.
- Scientists and experts specializing in cell technologies, gene therapy, and genetic engineering.
- Pioneers of artificial intelligence and its applications in life sciences and precision medicine.
Through this summit, the Kingdom seeks to lead the global dialogue on the future of health and to propose innovative solutions to intractable medical challenges, reflecting the pivotal role that Riyadh plays as an incubator for innovation and a center for attracting talent and investments in the promising biotechnology sector.
